37
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Evidence of a glycemic threshold for the development of cataracts in diabetic rats

, , , &
Pages 423-429 | Published online: 02 Jul 2009

References

  • Kador PF, Akagi Y, Kinoshita JH. The effect of aldose reductase and its inhibition on sugar cataract formation. Metabolism. 1986;35 (suppl):15–19.
  • Stevens VJ, Rouzer CA, Monnier VM, Cerami A. Dia-betic cataract formation: potential role of glycosylation of lens crystallins. Proc Natl Acad Sci USA, 1978;75: 2918–2922.
  • Perry RE, Swamy MS, Abraham EC. Progressive changes in lens crystallin glycation and high-molecular weightaggregate formation leading to cataract development in streptozotocin-diabetic rats. Exp Eye Res. 1989;44:269–282.
  • Swamy-Mruthinti S, Green K, Abraham EC. Inhibition of cataracts in moderately diabetic rats by aminogua-nidine. Exp Eye Res. 1996;62:505–510.
  • Hunt JV, Dean RT, Wolff SP. Hydroxyl radical produc-tion and autooxidative glycosylation. Biochem J. 1988;256:205–212.
  • Jedziniak JA, Chylack LT Jr, Cheng, H-M, Gillis MK, Kalustain AA, Tung WH. The sorbitol pathway in the human lens: Aldose reductase and polyol dehydrogenase. Invest Ophthalmol Vis Sci. 1981;20:314–326.
  • Srivastava SK and Ansari H. Prevention of sugar-induced cataractogenesis in rats by butylated hydroxytoluene. Diabetes. 1988;37:1505–1508.
  • Dunn JA, Patrick JS, Thorpe SR, Baynes JW Oxidation of glycated proteins: Age-dependent accumulation of NE-(carboxymethyplysine in lens proteins. Biochemistry. 1989;28:9464–9468.
  • Harding JJ, Crabbe MJC. The Lens: Development, Pro-teins, Metabolism and Cataract. In: The Eye (Ed. Davson H.) 1984; pp. 207–492. Academic Press, New York, Lon-don.
  • Peterson JW. Cause of diabetes and development of cataracts after injecting dehydroascorbic acid and related substances. Am J Physiol. 1951;165:61–65.
  • Peterson JW. Effect of lowered blood sugar on devel-opment of diabetic cataracts. Am J Physiol. 1953;172:77–82.
  • Swamy-Mruthinti S, Green K, Abraham E.C. Scheim-pflug densitometric analysis of cataracts in diabetic rats; correlation with glycation. Ophthalmic Res. 1996;28:230–236.
  • Hockwin 0, Dragomirescu V, Shabata T, Laser H, Wegener A. Long-term follow-up examination of ex-perimental cataracts in rats by Scheimpflug photogra-phy and densitometry. Graefes Arch Clin Exp Ophthal-mol. 1984;222:20–25.
  • Murano H, Kojima M, Sasaki K. Differences in naph-thalene cataract formation between albino and pigmented rat eyes. Ophthalmic Res. 1993;25:16–22.
  • Russell P, Robison WG, Kinoshita JH. A new method for rapid isolation of intrinsic membrane proteins from lens. Exp Eye Res. 1981;32:511–516.
  • Matzumoto K, Ikeda K, Horiuchi S, Zhao H, Abraham EC. Immunochemical evidence for increased formation of advanced glycation end products and inhibition of aminoguanidine in diabetic rat lenses. Biochem Biophys Res Commun. 1997;241:352–354.
  • Swamy MS, Abraham EC. Lens protein composition, glycation and high molecular weight aggregate forma-tion in aging rats. Invest Ophthalmol Vis Sci. 1987;28: 1693–1701.
  • Abraham EC, Perry RE, Abraham A, Swamy MS. Non-enzymatic glycosylation (glycation) of lens crystallins diabetes and aging. In: The Maillard Reaction in Aging, Diabetes, and Nutrition. (Ed. Baynes JW, Monnier VM) 1989; pp. 123–139. Alan R. Liss, Inc., New York, USA.
  • Nagaraj RH, Kern TS, Sell DR, Fogarty J, Engerman RL, Monnier VM. Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lenses but not in collagen. Diabetes. 1996;45:587–594.
  • Das B, Srivastava SK. Activation of aldose reductase from human tissues. Diabetes, 1985;34:1145–1151.
  • The Diabetes Control and Complications Trial Study Group. The absence of a glycemic threshold for the de-velopment of long-term complications — The perspec-tive of the diabetes control and complications trial. Dia-betes. 1996;45:1289–1298.
  • KrolewskiAS, Laffel LMB, Krolewski M, Quinn MA. Glycosylated hemoglobin and the risk of microalbumi-nuria in patients with insulin-dependent diabetes melli-tus. N Engl J Med 1995;332:1251–1255.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.